JP2018521119A5 - - Google Patents

Download PDF

Info

Publication number
JP2018521119A5
JP2018521119A5 JP2018515175A JP2018515175A JP2018521119A5 JP 2018521119 A5 JP2018521119 A5 JP 2018521119A5 JP 2018515175 A JP2018515175 A JP 2018515175A JP 2018515175 A JP2018515175 A JP 2018515175A JP 2018521119 A5 JP2018521119 A5 JP 2018521119A5
Authority
JP
Japan
Prior art keywords
methyl
isopropylthio
pyrazole
thiazol
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018515175A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018521119A (ja
JP6707630B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/035288 external-priority patent/WO2016196644A1/en
Publication of JP2018521119A publication Critical patent/JP2018521119A/ja
Publication of JP2018521119A5 publication Critical patent/JP2018521119A5/ja
Application granted granted Critical
Publication of JP6707630B2 publication Critical patent/JP6707630B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018515175A 2015-06-01 2016-06-01 置換ピラゾールおよびピロール化合物、および翻訳開始の阻害およびこれらに関連する疾患および障害の治療のためにこれらを用いる方法 Expired - Fee Related JP6707630B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562169376P 2015-06-01 2015-06-01
US62/169,376 2015-06-01
PCT/US2016/035288 WO2016196644A1 (en) 2015-06-01 2016-06-01 Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto

Publications (3)

Publication Number Publication Date
JP2018521119A JP2018521119A (ja) 2018-08-02
JP2018521119A5 true JP2018521119A5 (https=) 2019-10-03
JP6707630B2 JP6707630B2 (ja) 2020-06-10

Family

ID=56118071

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018515175A Expired - Fee Related JP6707630B2 (ja) 2015-06-01 2016-06-01 置換ピラゾールおよびピロール化合物、および翻訳開始の阻害およびこれらに関連する疾患および障害の治療のためにこれらを用いる方法

Country Status (9)

Country Link
US (2) US10537558B2 (https=)
EP (1) EP3303332A1 (https=)
JP (1) JP6707630B2 (https=)
CN (1) CN108349962A (https=)
BR (1) BR112017025851A2 (https=)
CA (1) CA3025492A1 (https=)
IL (1) IL255898A (https=)
MX (1) MX2017015456A (https=)
WO (1) WO2016196644A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3303332A1 (en) 2015-06-01 2018-04-11 Bantam Pharmaceutical, LLC Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto
MX2019006296A (es) * 2016-11-30 2019-11-12 Bantam Pharmaceutical Llc Métodos de uso de compuestos de pirazol y pirazol sustituido y para el tratamiento de enfermedades hiperproliferativas.
AU2017366901B2 (en) * 2016-11-30 2022-09-29 Bantam Pharmaceutical, Llc Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases
EP3778583B1 (en) 2018-03-30 2025-06-18 Sumitomo Chemical Company, Limited Heterocyclic compound and arthropod pest control composition containing same
WO2019236966A2 (en) 2018-06-07 2019-12-12 Bantam Pharmaceutical, Llc Methods of treatment of cancer with substituted pyrrole and pyrazole compounds and diagnosis of cancers susceptible to treatment with substituted pyrrole and pyrazole compounds
US12030875B2 (en) 2018-09-07 2024-07-09 PIC Therapeutics, Inc. EIF4E inhibitors and uses thereof
CN110950848B (zh) * 2018-09-27 2024-03-26 徐诺药业 新型氨基吡唑类衍生物的合成与应用
WO2020243582A1 (en) * 2019-05-31 2020-12-03 Bantam Pharmaceutical, Llc Methods for making thiszolylpyrazole carboxylic acids and intermediates therefor
JP7085697B2 (ja) 2019-11-01 2022-06-16 ユニマテック株式会社 含フッ素ピリミジン化合物およびその製造方法
AU2021230289A1 (en) * 2020-03-03 2022-09-29 PIC Therapeutics, Inc. eIF4E inhibitors and uses thereof
US12157732B2 (en) 2021-08-25 2024-12-03 PIC Therapeutics, Inc. eIF4E inhibitors and uses thereof
JP2024534127A (ja) 2021-08-25 2024-09-18 ピク セラピューティクス, インコーポレイテッド eIF4E阻害剤及びその使用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342851A (en) * 1992-10-07 1994-08-30 Mcneil-Ppc, Inc. Substituted thiazole derivatives useful as platelet aggregation inhibitors
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
DE60006057T2 (de) * 1999-12-03 2004-05-27 Pfizer Products Inc., Groton Heteroarylphenylpyrazolverbindungen zur Verwendung als analgetisches/entzündungshemmendes Mittel
US6900219B2 (en) 2002-04-04 2005-05-31 Cv Therapeutics, Inc. ABCA-1 elevating compounds
AU2004228057A1 (en) 2003-04-03 2004-10-21 Merck & Co., Inc. Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5
EP1618099A4 (en) 2003-04-18 2008-07-16 Merck & Co Inc BIARYLSUBSTITUTED DIAZOLE, OXAZOLE AND IMIDAZOLE AS SODIUM CHANNEL BLOCKERS
WO2007138110A2 (en) * 2006-06-01 2007-12-06 Devgen N.V. Compounds that interact with ion channels, in particular with ion channels from the kv family
WO2008121861A2 (en) 2007-03-28 2008-10-09 Xenon Pharmaceuticals Inc. Pyrazole and pyrrole compounds useful in treating iron disorders
US8642597B2 (en) 2007-08-27 2014-02-04 Basf Se Pyrazole compounds for controlling invertebrate pests
CN102056907B (zh) 2008-04-04 2014-12-31 武田药品工业株式会社 杂环衍生物及其用途
SI2275414T1 (sl) 2008-04-28 2015-10-30 Kyorin Pharmaceutical Co., Ltd., Ciklopentilakrilamidni derivat
EP2651405A2 (en) * 2010-12-14 2013-10-23 Electrophoretics Limited Casein kinase 1 (ck1 ) inhibitors
US9409901B2 (en) 2012-10-22 2016-08-09 Bantam Pharmaceutical, Llc Compositions and methods for treating or preventing diseases or disorders associated with misregulated EIF4E
JP6434989B2 (ja) 2014-03-27 2018-12-05 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung ピリジルピペリジン
US10125139B2 (en) 2015-04-24 2018-11-13 Syngenta Crop Protection Ag Pesticidally active polycyclic derivatives with sulfur substituted five-membered ring heterocycles
EP3303332A1 (en) 2015-06-01 2018-04-11 Bantam Pharmaceutical, LLC Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto

Similar Documents

Publication Publication Date Title
JP2018521119A5 (https=)
JP2007510689A5 (https=)
RU2457207C2 (ru) Активаторы глюкокиназы
RU2426731C2 (ru) Производные арил-изоксазоло-4-ил-оксадиазола
RU2013143028A (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
JP2016513660A5 (https=)
JP2010533158A5 (https=)
RU2014152625A (ru) Конденсированные с гетероарилкетонами азадекалины - модуляторы глюкокортикоидных рецепторов
JP2009524670A5 (https=)
RU2005123484A (ru) Новые производные пиридазин-3(2н)-она
RU2006112046A (ru) Производные пиррола с антибактериальным действием
HRP20212000T1 (hr) Aminotriazolopiridini kao inhibitori kinaze
JP2016526576A5 (https=)
JP2015517580A5 (https=)
RU2010150786A (ru) Пирролопиридины как ингибиторы киназы
JP2017525757A5 (https=)
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
JP2006500348A5 (https=)
RU2012126989A (ru) 2-амино-5,5-дифтор-5,6-дигидро-4н-оксазины в качестве ингибиторов васе 1 и(или) васе 2
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
CA2729557A1 (en) Chemical compounds 251
JP2017508766A5 (https=)
JP2010540462A5 (https=)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2011503230A5 (https=)